Technical Analysis for BFRI - Biofrontera Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.09 | -11.38% | -0.14 |
BFRI closed down 11.38 percent on Friday, November 1, 2024, on approximately normal volume. It was able to find support at its 50 day moving average. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Nov 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Shooting Star Candlestick | Bearish | -11.38% | |
| 20 DMA Support | Bullish | -11.38% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 22 hours ago |
| 50 DMA Support | about 23 hours ago |
| Down 1 ATR | about 23 hours ago |
| 60 Minute Opening Range Breakdown | about 24 hours ago |
| Fell Below 50 DMA | about 24 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2024
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Antineoplastic Drugs Melanoma Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Antineoplastic Drugs Melanoma Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.39 |
| 52 Week Low | 0.61 |
| Average Volume | 3,167,408 |
| 200-Day Moving Average | 1.19 |
| 50-Day Moving Average | 1.07 |
| 20-Day Moving Average | 0.89 |
| 10-Day Moving Average | 0.98 |
| Average True Range | 0.20 |
| RSI (14) | 55.56 |
| ADX | 26.15 |
| +DI | 49.62 |
| -DI | 7.97 |
| Chandelier Exit (Long, 3 ATRs) | 1.61 |
| Chandelier Exit (Short, 3 ATRs) | 1.30 |
| Upper Bollinger Bands | 1.13 |
| Lower Bollinger Band | 0.65 |
| Percent B (%b) | 0.92 |
| BandWidth | 53.25 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0397 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.44 | ||||
| Resistance 3 (R3) | 1.45 | 1.35 | 1.38 | ||
| Resistance 2 (R2) | 1.35 | 1.26 | 1.34 | 1.36 | |
| Resistance 1 (R1) | 1.22 | 1.21 | 1.17 | 1.21 | 1.34 |
| Pivot Point | 1.12 | 1.12 | 1.10 | 1.11 | 1.12 |
| Support 1 (S1) | 0.99 | 1.03 | 0.94 | 0.98 | 0.84 |
| Support 2 (S2) | 0.89 | 0.98 | 0.88 | 0.82 | |
| Support 3 (S3) | 0.76 | 0.89 | 0.80 | ||
| Support 4 (S4) | 0.75 |
